Chongqing Zhifei Bio Products Cash Flow Quality Index
Chongqing Zhifei Bio Products cash flow quality index. Chongqing Zhifei Bio Products (300122) has a Cash Flow Quality Index of 5.11x as of June 2024. Operating cash flow of CN¥3.97 Billion exceeds net income of CN¥776.58 Million, indicating high earnings quality where cash backs reported profits. See Chongqing Zhifei Bio Products free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Chongqing Zhifei Bio Products (2007–2024)
Cash flow quality index of Chongqing Zhifei Bio Products from 2007 to 2024. Historical Cash Flow Quality Index for Chongqing Zhifei Bio Products across 18 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Chongqing Zhifei Bio Products to assess how comfortably operating cash covers total debt obligations.
Chongqing Zhifei Bio Products Cash Flow Quality Index by Year (2007–2024)
Chongqing Zhifei Bio Products cash flow quality index by year from 2007 to 2024. Year-by-year earnings quality comparison for Chongqing Zhifei Bio Products. For the full cash flow conversion analysis, see 300122 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -2.19x | CN¥-4.41 Billion | CN¥2.02 Billion | ▼ -296.2% |
| 2023 | 1.11x | CN¥9.00 Billion | CN¥8.07 Billion | ▲ +322.5% |
| 2022 | 0.26x | CN¥1.99 Billion | CN¥7.54 Billion | ▼ -68.3% |
| 2021 | 0.83x | CN¥8.51 Billion | CN¥10.21 Billion | ▼ -21.3% |
| 2020 | 1.06x | CN¥3.50 Billion | CN¥3.30 Billion | ▲ +83.4% |
| 2019 | 0.58x | CN¥1.37 Billion | CN¥2.37 Billion | ▲ +43.2% |
| 2018 | 0.40x | CN¥585.59 Million | CN¥1.45 Billion | ▼ -14.3% |
| 2017 | 0.47x | CN¥203.61 Million | CN¥432.28 Million | ▼ -83.0% |
| 2016 | 2.77x | CN¥89.95 Million | CN¥32.52 Million | ▲ +144.4% |
| 2015 | 1.13x | CN¥223.45 Million | CN¥197.40 Million | ▲ +3.8% |
| 2014 | 1.09x | CN¥161.39 Million | CN¥148.00 Million | ▼ -35.9% |
| 2013 | 1.70x | CN¥221.58 Million | CN¥130.35 Million | ▲ +228.2% |
| 2012 | 0.52x | CN¥112.89 Million | CN¥217.94 Million | ▼ -54.0% |
| 2011 | 1.13x | CN¥221.25 Million | CN¥196.38 Million | ▲ +433.9% |
| 2010 | 0.21x | CN¥54.19 Million | CN¥256.79 Million | ▼ -76.8% |
| 2009 | 0.91x | CN¥210.61 Million | CN¥231.59 Million | ▲ +22.1% |
| 2008 | 0.74x | CN¥141.58 Million | CN¥190.05 Million | ▲ +1.4% |
| 2007 | 0.73x | CN¥111.66 Million | CN¥152.01 Million | — |